DSAEK with Ultra-Thin Tissue vs. DMEK

Presented by Bennie Jeng, M.D.

What's better: DMEK or DSAEK with Ultra-Thin tissue?

Is there a definitive answer? Is one procedure truly better than the other, or is it all perception?

Join Dr. Bennie Jeng as he shares his discoveries after comparing the two types of surgeries and their impacts on patients who have had successful recoveries. The answers may surprise you....


Comparing the two types of surgeries and their impacts on patients who have had successful recoveries.

✓ A look at the current and past research published by other leading surgeons in the field.
✓ Surgical techniques in relation to doing corneal transplants with ultra-thin tissue.


Meet the Presenter: Bennie Jeng, M.D.
Dr. Jeng, a leading expert in cornea and external disease, joined the University of Maryland School of Medicine from the University of California, San Francisco (UCSF) where he worked as a Professor of Ophthalmology and Co-Director of the Cornea Service. He also served as Chief of the Department of Ophthalmology at the San Francisco General Hospital, and was the Director of the Francis I. Proctor Foundation/UCSF Cornea Fellowship Program.

Dr. Jeng completed his undergraduate work at Washington University in St. Louis and then earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania. Following an internship at the Cleveland Clinic, he completed his ophthalmology residency training at the Cole Eye Institute of the Cleveland Clinic, where he served as Chief Resident in his last year. He then did his fellowship training in cornea, external diseases, refractive surgery, and uveitis at the Franics I. Proctor Foundation/ UCSF. Upon completion of his fellowship, he returned to the Cleveland Clinic to serve on the faculty, during which time he established a busy medical and surgical cornea practice.

Dr. Jeng is a physician-scientist who has published more than 60 peer-reviewed manuscripts and 15 book chapters. He has delivered more than 100 invited lectures in the U.S. and around the world. He also serves on the editorial boards of both JAMA Ophthalmology and Eye.